Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2600116021) titled 'Study on the efficacy and safety of treating acute radioactive skin injury by external application of Artemisia Detoxification Prescription' on Jan. 4.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Xiyuan Hospital of China Academy of Chinese Medical Sciences
Condition:
acute radioactive skin injury
Intervention:
Experimental group:external application of Artemisia Detoxification Prescription
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2024-05-30
Target Sample Size: Experimental group:25;Controlled group:25;
Countries of Recruitment:
China
To ...